Zhejiang Xianju Pharmaceutical Faces Declining Sales and Profit Amid Market Challenges

Zhejiang Xianju Pharmaceutical Co., Ltd. has recently experienced an adjustment in its evaluation, reflecting ongoing trends within the company and the broader market. The stock's technical indicators have shown a shift, with the technical trend moving to a bearish stance. This adjustment comes in light of the company's financial metrics, which have indicated challenges over recent periods. The company reported a decline in net sales, with a notable annual growth rate of -1.39% over the past five years, and a significant drop of -8.91% in net sales for the quarter ending September 2025. Additionally, operating profit has also faced a downturn, registering a -6.83% change during the same timeframe. The operating cash flow has reached a low point of CNY 312.95 million, and the return on capital employed (ROCE) has been recorded at 4.56%, marking a concerning trend for the company. Zhejiang Xianju Pharmaceutical has consistently underperformed against market benchmarks, including the China Shanghai Composite, over the last three years, with returns of -2.77% in the past year. This context provides insight into the recent revision in its score, highlighting the challenges the company faces in the current market landscape. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.